Market Research Future (MRFR) revealed several possible factors that can impact market growth. These factors are the growing demand for anti-clotting agents during various types of treatments. Increasing cardiovascular disease is also a major reason for the growth of the oral anticoagulants market. Other reasons include a hike in geriatric populations and increasing surgical procedures. But the cost is too high for these products, which can restraint market growth. However, the demand for better support during various surgeries may inspire the growth of the market.
The major key players of the global oral anticoagulant market are as follows.
AstraZeneca, Plc (UK)
Pfizer (US)
Boehringer Ingelheim GmbH (Germany)
Daiichi Sankyo Company Ltd (Japan)
Abbott Laboratories (US)
Eli Lilly and Company (US)
GlaxoSmithKline plc (UK) Portola Pharmaceuticals Inc. (US)
Medicure (Canada), Johnson & Johnson Services Inc. (US)
Regional Analysis
Geographically, the Americas is expected to dominate the global oral anticoagulants market. This is owing to increasing cardiovascular disorders and increasing surgical procedures. Europe showed a considerable amount of growth in the market due to the rising geriatric population. Asia-Pacific is estimated to be the fastest growing region in the market. This is owing to increasing cardiovascular disorders and rising geriatric population. On the other hand, the Middle East & Africa has the least share of the market.
The global oral anticoagulants market has been segmented into product, disease indication, distribution channel, and region. Based on product, the oral anticoagulants market has been segmented into novel oral anticoagulant and warfarin. On the basis of disease indication, the global oral anticoagulants market has been segmented into atrial fibrillation (AF)/ stroke prevention and deep vein thrombosis/ pulmonary embolism, and others. On the basis of distribution channel, the global oral anticoagulants market has been segmented into hospital pharmacies, retail pharmacies, and E-commerce.
Key Findings of the Study:
Global oral anticoagulants market is projected to reach USD 22,561.24 million by 2023 with 12.50% CAGR during the review period of 2018 to 2023
Americas accounted for the largest share due to in the region
The atrial fibrillation (AF)/stroke prevention segment, is accounted for the largest share, holding a market value of USD 49 in 2017.
Some of the players operating in the oral anticoagulants market are AstraZeneca, Plc, Pfizer, Boehringer Ingelheim GmbH, Daiichi Sankyo Company Ltd, Abbott Laboratories among others.
This research report provides the insights, on various levels of analyses such as industry analysis, market share analysis leading market players and their profiles. This report also helps in studying the target segments by providing views on emerging & high-growth segments and market conclusion. Together the market data comprise and discuss with the basic assessments on the competitive scenarios & strategies, of the Global Oral Anticoagulants Market, including the high-growth regions and their political, economic and technological environments. Furthermore, the project report also provides the views over the historical market values as well as, pricing and cost analysis of the same.
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),